Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C.

Fabris, Paolo; Brown, Dave; Tositti, Giulia; Bozzola, Loredana; Giordani, Maria Teresa; Bevilacqua, Pierantonio; de Lalla, Fausto; Webster, George J M; Dusheiko, Geoffrey

Fabris, Paolo; Brown, Dave; Tositti, Giulia; Bozzola, Loredana; Giordani, Maria Teresa; Bevilacqua, Pierantonio; de Lalla, Fausto; Webster, George J M; Dusheiko, Geoffrey.

Affiliation

Fabris P; Department of Infectious Diseases and Tropical Medicine, S. Bortolo Hospital, Viale Rodolfi, Vicenza 36100, Italy. pfabris@yahoo.com

J Clin Virol ; 29(3): 160-6, 2004 Mar.

Article in En | MEDLINE | ID: mdl-14962784

Subject(s)

Antiviral Agents/therapeutic use; Hepatitis B Surface Antigens/blood; Hepatitis B/complications; Hepatitis C, Chronic/complications; Liver/pathology; Substance Abuse, Intravenous/complications; Adult; Antiviral Agents/administration & dosage; DNA, Viral/analysis; Drug Therapy, Combination; Female; Hepatitis B/drug therapy; Hepatitis B/virology; Hepatitis B virus/genetics; Hepatitis B virus/isolation & purification; Hepatitis C, Chronic/drug therapy; Hepatitis C, Chronic/pathology; Hepatitis C, Chronic/virology; Humans; Interferon alpha-2; Interferon-alpha/administration & dosage; Interferon-alpha/therapeutic use; Liver/virology; Male; Middle Aged; Recombinant Proteins; Ribavirin/administration & dosage; Ribavirin/therapeutic use; Severity of Illness Index; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Substance Abuse, Intravenous / Hepatitis C, Chronic / Hepatitis B / Hepatitis B Surface Antigens / Liver Type of study: Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Virol Journal subject: VIROLOGIA Year: 2004 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links